These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10645825)

  • 1. Re: "Syringe exchange and risk of infection with hepatitis B and C viruses".
    Voth EA
    Am J Epidemiol; 2000 Jan; 151(2):207-8. PubMed ID: 10645825
    [No Abstract]   [Full Text] [Related]  

  • 2. Who: four ways to reduce hepatitis infections in people who inject drugs.
    Cent Eur J Public Health; 2012 Sep; 20(3):207. PubMed ID: 23285521
    [No Abstract]   [Full Text] [Related]  

  • 3. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program.
    Månsson AS; Moestrup T; Nordenfelt E; Widell A
    Scand J Infect Dis; 2000; 32(3):253-8. PubMed ID: 10879594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syringe exchange and risk of infection with hepatitis B and C viruses.
    Hagan H; McGough JP; Thiede H; Weiss NS; Hopkins S; Alexander ER
    Am J Epidemiol; 1999 Feb; 149(3):203-13. PubMed ID: 9927214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut.
    Grau LE; Zhan W; Heimer R
    Drug Alcohol Rev; 2016 Sep; 35(5):628-36. PubMed ID: 27073014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid spread of hepatitis C and needle exchange programme in Kolkata, India.
    Sarkar K; Mitra S; Bal B; Chakraborty S; Bhattacharya SK
    Lancet; 2003 Apr; 361(9365):1301-2. PubMed ID: 12699985
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV revisited: preventing the spread of blood-borne viruses among injecting drug users.
    Wodak A; Crofts N
    Aust J Public Health; 1994 Sep; 18(3):239-41. PubMed ID: 7841248
    [No Abstract]   [Full Text] [Related]  

  • 8. Ongoing HIV and viral hepatitis infections in IDUs across the EU, 2001-2005.
    Wiessing L; Nardone A
    Euro Surveill; 2006 Nov; 11(11):E061123.2. PubMed ID: 17213556
    [No Abstract]   [Full Text] [Related]  

  • 9. Syringe access programs.
    J Assoc Nurses AIDS Care; 2012; 23(3):272-4. PubMed ID: 22645744
    [No Abstract]   [Full Text] [Related]  

  • 10. Knowledge of hepatitis among active drug injectors at a syringe exchange program.
    Carey J; Perlman DC; Friedmann P; Kaplan WM; Nugent A; Deutscher M; Masson CL; Des Jarlais DC
    J Subst Abuse Treat; 2005 Jul; 29(1):47-53. PubMed ID: 15979531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cruel and unusual punishment.
    Crofts N
    Med J Aust; 1997 Feb; 166(3):116. PubMed ID: 9059429
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.
    Hagan H; Thiede H
    J Urban Health; 2000 Sep; 77(3):369-82. PubMed ID: 10976611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.
    Hagan H; Jarlais DC; Friedman SR; Purchase D; Alter MJ
    Am J Public Health; 1995 Nov; 85(11):1531-7. PubMed ID: 7485666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic steroid users identified by needle and syringe exchange contact.
    Morrison CL
    Drug Alcohol Depend; 1994 Oct; 36(2):153-5. PubMed ID: 7851283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany.
    Stark K; Herrmann U; Ehrhardt S; Bienzle U
    Epidemiol Infect; 2006 Aug; 134(4):814-9. PubMed ID: 16371183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower syringe sharing and re-use after syringe legalization in Rhode Island.
    Rich JD; Hogan JW; Wolf F; DeLong A; Zaller ND; Mehrotra M; Reinert S
    Drug Alcohol Depend; 2007 Jul; 89(2-3):292-7. PubMed ID: 17386980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The current problems in the epidemiology and prevention of viral hepatitis B and C in the Russian Federation].
    Onishchenko GG; Shakhgil'dian IV
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (1):50-4. PubMed ID: 10876894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transmission of hepatitis B and C viruses from caregiver to patients: myths and reality].
    Bourlière M
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):291-3. PubMed ID: 12700515
    [No Abstract]   [Full Text] [Related]  

  • 19. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Law MG; Batey RG
    Med J Aust; 2003 Mar; 178(5):197-8. PubMed ID: 12603178
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis vaccination among drug users.
    Quaglio G; Lugoboni F; Mezzelani P; Des Jarlais DC; Lechi A
    Vaccine; 2006 Apr; 24(15):2702-9. PubMed ID: 16436307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.